| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$418 |
Proposed issue of securities - RAC
|
4 Jun 2026 8:52AM |
$2.510 |
$2.130 |
fallen by
15.14%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$25,966 |
Notification of cessation of securities - BXB
|
4 Jun 2026 8:51AM |
$16.400 |
$19.440 |
risen by
18.54%
|
|
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$2,414 |
Update - Notification of buy-back - AUI
|
4 Jun 2026 8:51AM |
$10.860 |
$11.090 |
risen by
2.12%
|
|
| Platinum International Fund (Quoted Managed Hedge Fund) (PIXX) |
Financials |
$64 |
Monthly redemptions and units on issue May 2026
|
4 Jun 2026 8:50AM |
$5.030 |
$4.840 |
fallen by
3.78%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$418 |
Emerging Companies Specialist Invests in Racura
|
4 Jun 2026 8:50AM |
$2.510 |
$2.130 |
fallen by
15.14%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Racura Oncology secures support from a specialist institutional investor through a private placement.
- The placement involves 526,315 shares at $1.90 per share, a 23% discount to the average market price as of June 3.
- The placement complements funds from Piggyback and Bonus Options, raising a total of $31.2 million.
- Funds will support the clinical development of RC220 and general working capital.
- Racura's lead asset, (E,E)-bisantrene, targets the MYC cancer growth regulator.
- Racura is advancing RC220 in Phase 3 trials for acute myeloid leukaemia and other oncology indications.
- Racura collaborates with several academic and research institutions.
- No broker fees were involved in the placement, minimizing dilution to existing shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$10 |
Tartana Copper resource expansion drilling continues
|
4 Jun 2026 8:49AM |
$0.023 |
$0.025 |
risen by
8.70%
|
|
TAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drillhole D10 completed to 291.1m at Tartana Copper Project.
- Drilling in progress for hole D11 with a target depth of 350m.
- Campaign aims to increase copper resource from 45,000 tonnes.
- Drilling focuses on Northern Zone, Open Pit Area, and Deeper Drilling Zone.
- 50,000 tonnes of pit fill material stacked for copper sulfate production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$397 |
Update - Notification of buy-back - KGN
|
4 Jun 2026 8:47AM |
$4.160 |
$4.190 |
risen by
0.72%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$406 |
Viridis Executes First Major Project Delivery Contract
|
4 Jun 2026 8:47AM |
$3.550 |
$3.120 |
fallen by
12.11%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Viridis Mining and Minerals Limited executes its first major project delivery contract.
- The contract is with a municipal electricity distributor (DME) for power transmission infrastructure.
- The infrastructure connects the Colossus Rare Earth Project to the Brazilian electricity grid.
- The agreement includes a 3.2km, 138kV high-voltage transmission line and reserved power allocation.
- Reserved grid capacity aligns with a development schedule aiming for first production in H1 2028.
- DME provides a turnkey delivery solution reducing execution risks.
- The infrastructure is designed for future expansion without significant additional investment.
- The connection works package is valued at approximately BRL3.97 million.
- DME has commenced procurement activities for critical electrical equipment.
- This agreement is a significant milestone towards Viridis' Final Investment Decision in H2 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asia Fund (Quoted Managed Hedge Fund) (PAXX) |
Financials |
$271 |
Monthly redemptions and units on issue May 2026
|
4 Jun 2026 8:47AM |
$6.800 |
$5.740 |
fallen by
15.59%
|
|
| Dexus Convenience Retail REIT (DXC) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$362 |
Update - Notification of buy-back - DXC
|
4 Jun 2026 8:46AM |
$2.520 |
$2.670 |
risen by
5.95%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$51 |
New Strata Payments, NAB Banking Integration and Portal
|
4 Jun 2026 8:46AM |
$0.660 |
$0.640 |
fallen by
3.03%
|
|
UBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Urbanise.Com Limited announced new strata payment functionalities and NAB banking integration.
- Introduction of the Urbanise Owners Portal with Payments and Levies capabilities.
- Integration aims to streamline management by connecting payments, banking, and self-service.
- Phased rollout targeted from July 2026, with early adopter pilot releases.
- Portal supports PayID and PayTo, enhancing digital payment methods.
- Designed to improve operational efficiency and owner experience in strata management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dexus Industria REIT (DXI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$787 |
Update - Notification of buy-back - DXI
|
4 Jun 2026 8:45AM |
$2.340 |
$2.520 |
risen by
7.69%
|
|
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$6 |
Strong Infill Auger Results Confirm Tunas REE Continuity
|
4 Jun 2026 8:45AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong infill auger results at Tunas Project confirm continuity of REE mineralisation.
- Highest grades were found in the lower saprolite profile, near the transition into saprock.
- Significant REE mineralisation hosted in saprolitic clays within the Tunas Project, Brazil.
- A total of 19 auger holes were completed, with 14 pending assay results.
- Potential expansion indicated as all mineralisation remains open at depth.
- Leachability testwork ongoing to assess ionic adsorption clay potential.
- Auger drilling supports the prospectivity of near-surface rare earth mineralisation.
- Results showed significant MREO content, with peak value up to 41% of TREO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$620 |
Update - Notification of buy-back - FPR
|
4 Jun 2026 8:45AM |
$2.740 |
$2.900 |
risen by
5.84%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$6 |
97% Gold Recovery at Waihi Deposit
|
4 Jun 2026 8:45AM |
$0.016 |
$0.013 |
fallen by
18.75%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- 97% gold recovery achieved at Waihi deposit
- Tests conducted on weathered saprock and fresh rock domains
- Consistent results with previous Korong deposit findings
- Supports a unified processing strategy for the Monument Gold Project
- Low reagent consumption indicating cost-efficient processing
- Gravity recovery supports a straightforward processing pathway
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$22 |
DTM: More High-grade Gold, Silver, and Antimony at Banshee
|
4 Jun 2026 8:44AM |
$0.350 |
$0.325 |
fallen by
7.14%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gold, silver, and antimony discovered at Banshee.
- Detailed drill hole results presented.
- Potential for further exploration and development.
- Significant mineralization in specific drill intervals.
- Banshee site shows promise for future mining operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$3 |
More High-grade Gold, Silver, and Antimony at Banshee
|
4 Jun 2026 8:44AM |
$0.019 |
$0.013 |
fallen by
29.73%
|
|
DTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant high-grade gold, silver, and antimony findings at Banshee.
- Exploration confirms potential economic viability of the site.
- Elevated mineral concentrations across several drill holes.
- Prospective area aligns with strategic goals for development.
- Focus on advancing exploration to define resource potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$321 |
Update - Notification of buy-back - PAC
|
4 Jun 2026 8:43AM |
$10.800 |
$11.500 |
risen by
6.48%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,141 |
Notification of cessation of securities - GYG
|
4 Jun 2026 8:41AM |
$19.200 |
$21.500 |
risen by
11.98%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$157 |
Update - Notification of buy-back - WJL
|
4 Jun 2026 8:40AM |
$0.365 |
$0.400 |
risen by
9.59%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$162 |
Halfway Mark Reached in Optiscan Breast Cancer Study
|
4 Jun 2026 8:39AM |
$0.130 |
$0.155 |
risen by
19.23%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Halfway milestone reached in Optiscan’s breast cancer study.
- 25 out of 50 target patients have been imaged.
- Study employs InVue® for in vivo and InForm® for ex vivo imaging.
- FDA submissions for both devices expected in second half of 2026.
- Study expanded to a second site for accelerated recruitment.
- Key step towards commercialisation and U.S. market entry.
- Potential to reduce need for re-operative surgeries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$7,273 |
Update - Notification of buy-back - CGF
|
4 Jun 2026 8:39AM |
$9.030 |
$10.670 |
risen by
18.16%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,532 |
Update - Notification of buy-back - AFI
|
4 Jun 2026 8:39AM |
$6.520 |
$6.930 |
risen by
6.29%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$15 |
Final Director's Interest Notice - Helen Foley
|
4 Jun 2026 8:38AM |
$0.230 |
$0.230 |
fallen by
0%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$15 |
Director Resignation - Helen Foley
|
4 Jun 2026 8:38AM |
$0.230 |
$0.230 |
fallen by
0%
|
|